Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$8,848,195
+$2,235,969 QoQ
Shares Held
7,377
+2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,333
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. LLY ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
|
15,186 | $2,879,569 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,848,195 | 7,377 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $6,612,226 | 7,189 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,487,296 | 6,967 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,686,346 | 6,142 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,243,118 | 6,726 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,321,338 | 6,443 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,280,480 | 6,840 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,878,664 | 8,893 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,882,238 | 8,706 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,245,006 | 6,742 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,930,046 | 6,742 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,654,095 | 6,803 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,705,410 | 7,901 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,470,563 | 7,194 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $3,282,682 | 8,973 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,846,651 | 5,711 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,729,767 | 5,335 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,219,363 | 4,258 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,066,485 | 3,861 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $753,223 | 3,260 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,359,446 | 5,923 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,733,876 | 9,281 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,007,974 | 5,970 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $854,815 | 5,775 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $997,886 | 6,078 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $622,436 | 4,487 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||